EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Midlife Steroid‐Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women

Rachel F Buckley iD, Matthew Scott, Emer R McGrath, Gillian Coughlan iD, Mabel Seto, Saptaparni Ghosh, Heidi I L Jacobs iD, Claudia L Satizabal iD, Emma Thibault, Vasan Ramachandran, Joanne M Murabito, Reisa A Sperling und 5 weitere

Annals of Neurology · 2025

DOI: 10.1002/ana.27266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2025. Verfasst von Rachel F Buckley und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA. Hauptthemen laut MEDLINE: Sex Hormone-Binding Globulin, tau Proteins, Testosterone, Brain. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, NINDS NIH HHS, National Institute on Aging.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

In men and women, sex steroid hormones have been associated with increased risk of Alzheimer's disease (AD) dementia. We aimed to investigate the influence of midlife testosterone and sex hormone binding globulin (SHBG) levels on later‐life in vivo markers of β‐amyloid (Aβ) and tau deposition in clinically healthy older men.

Methods

This time‐lagged study includes participants enrolled in the Framingham Heart Study (FHS) Third Generation cohort. One hundred fifty‐nine men (mean age PET‐scan = 58 [±/9] years) underwent blood (hormones) collection in 2002 to 2005, and then a single Aβ 11 C‐Pittsburgh Compound B (PiB) PiB‐positron emission tomography (PET) and 18 F‐Flortaucipir (FTP)‐PET scan in 2016 to 2020. Linear regressions examined sex‐stratified associations among total testosterone, and SHBG with Aβ‐PET, and tau‐PET after adjusting for age. Separate models examined the moderating effect of Aβ‐PET and APOE ε4.

Results

In men, the elevated SHBG level was associated with lower tau‐PET in entorhinal (B unstandardized = −0.001 [SE = 0.0005], p = 0.007), inferior temporal (B unstandardized = −0.001 [SE = 0.0004], p = 0.04), and rostral middle frontal regions (B unstandardized = −0.001 [SE = 0.0004], p = 0.02). These findings were largely driven by APOE ε4 non‐carriers. Testosterone levels were not associated with the Aβ‐PET or tau‐PET signal.

Interpretation

We report a potential protective effect of SHBG levels on tau‐PET burden in men. Higher levels of SHBG have been associated with lower risk of vascular‐related comorbidities, such as obesity and diabetes, and is regulated by modifiable lifestyle factors. Given mounting evidence of a link between vascular injury and tauopathy in preclinical AD, our findings suggest an intriguing protective cardiovascular pathway for men against higher tau burden later in life. ANN NEUROL 2025;98:524–532

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sex Hormone-Binding Globulintau ProteinsTestosteroneBrainHumansMaleFemaleAgedMiddle AgedPositron-Emission TomographyNeuroimagingAmyloid beta-PeptidesBiomarkersAlzheimer DiseaseCohort Studies

Substanzen

Sex Hormone-Binding Globulintau ProteinsTestosteroneAmyloid beta-PeptidesSHBG protein, humanBiomarkersMAPT protein, human

Autor:innen und Institutionen

  • Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston, MA.
  • Melbourne School of Psychological Sciences, University of Melbourne, Melbourne, Victoria, Australia.
  • Framingham Heart Study, Framingham, MA.
  • Department of Biostatistics, Boston University School of Public Health, Boston, MA.
  • HRB Clinical Research Facility, National University of Ireland Galway, Galway, Ireland.

ORCID-Profile: Rachel F Buckley, Gillian Coughlan, Heidi I L Jacobs, Claudia L Satizabal

Förderung

  • NIA NIH HHS
  • NINDS NIH HHS
  • National Institute on Aging

Zitieren

APA

Buckley, R. F., Scott, M., McGrath, E. R., Coughlan, G., Seto, M., Ghosh, S., Jacobs, H. I. L., Satizabal, C. L., Thibault, E., Ramachandran, V., Murabito, J. M., Sperling, R. A., Johnson, K. A., Jasuja, R., Bhasin, S., Seshadri, S., & Beiser, A. S. (2025). Midlife Steroid‐Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women. Annals of Neurology. https://doi.org/10.1002/ana.27266

Vancouver

Buckley RF, Scott M, McGrath ER, Coughlan G, Seto M, Ghosh S, et al. Midlife Steroid‐Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women. Annals of Neurology. 2025. doi:10.1002/ana.27266

BibTeX
@article{Buckley2025,
  author = {Buckley, Rachel F and Scott, Matthew and McGrath, Emer R and Coughlan, Gillian and Seto, Mabel and Ghosh, Saptaparni and Jacobs, Heidi I L and Satizabal, Claudia L and Thibault, Emma and Ramachandran, Vasan and Murabito, Joanne M and Sperling, Reisa A and Johnson, Keith A and Jasuja, Ravi and Bhasin, Shalender and Seshadri, Sudha and Beiser, Alexa S},
  title = {Midlife Steroid‐Binding Globulin Levels and In Vivo Neuroimaging Measures of Tau in Older Men and Women},
  journal = {Annals of Neurology},
  year = {2025},
  doi = {10.1002/ana.27266}
}
Kostenlos starten →